Apogee Therapeutics, Inc. APGE Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s cash ratio?
- Apogee Therapeutics, Inc. (APGE) reported cash ratio of 13.7× in Q1 2026.
- How has Apogee Therapeutics, Inc.'s cash ratio changed year-over-year?
- Apogee Therapeutics, Inc.'s cash ratio increased by 322.7% year-over-year, from 3.2× to 13.7×.
- What is the long-term trend for Apogee Therapeutics, Inc.'s cash ratio?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s cash ratio has grown at a -32.3% compound annual growth rate (CAGR), from 15.2× to 4.7×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.